NON-IMIDAZOLE ARYL ALKYLAMINES COMPOUNDS AS HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES

Details for Australian Patent Application No. 2002254114 (hide)

Owner ELI LILLY AND COMPANY

Inventors NIXON, James, Arthur; PICKARD, Richard, Todd; SCHAUS, John, Mehnert; TAKAKUWA, Takako; WATSON, Brian, Morgan; BEAVERS, Lisa, Selsam; GADSKI, Robert, Alan; HIPSKIND, Philip, Arthur; LINDSLEY, Craig, William; LOBB, Karen, Lynn

Pub. Number AU-A-2002254114

PCT Pub. Number WO2002/076925

Priority 60/278,230 23.03.01 US

Filing date 21 March 2002

Wipo publication date 8 October 2002

International Classifications

C07C 217/58 Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 311/18 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 237/08 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07D 295/14 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07C 217/74 Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 271/34 Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 323/62 Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07C 271/24 Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 233/73 Carboxylic acid amides

C07C 237/32 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 311/17 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 409/12 Peroxy compounds

C07D 207/16 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 409/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

C07D 307/46 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/12 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 241/44 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 031/395 - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 031/131 - acyclic

A61P 003/00 Drugs for disorders of the metabolism

A61P 025/00 Drugs for disorders of the nervous system

C07D 295/08 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/12 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07C 217/20 Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 311/05 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/13 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002254114

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002254115-DIGITAL ENTERTAINMENT SERVICE PLATFORM

2002254113-IDENTIFICATION AND CHARACTERIZATION OF A WAXY CURLED LEAF PHENOTYPE (WCL1) IN ARABIDOPSIS